The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease
Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…Assessing the Accuracy of Clinical features, CSF Dopamine Metabolites, and Striatal Binding Ratios for the Likelihood of Depression Over 10-year Follow Up in the PPMI Cohort.
Objective: To identify whether MDS-UPDRS scores, Dopamine Transporter (DaT) Striatal Binding Ratios (SBRs), or dopamine metabolites cerebrospinal fluid (CSF) concentrations could predict the likelihood of…Social phobia, anxiety and depression in patients with essential tremor
Objective: ET is the most diagnosed movement disorder, the frequency of which increases as a person ages. Background: To examine the incidence of social phobia,…Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort
Objective: This study aims to:(1) Explore the feasibility of delivering a web application to enable social interaction and analyse digital social characteristics.(2) Gather insights into…The comorbidity conundrum in functional movement disorder: How are FMD patients with additional other FND different?
Objective: This study aimed to compare patients with isolated Functional Movement Disorders [FMD-i] to those with associated co-morbid other Functional Neurological Disorders(FND) [FMD+]. Background: FMD…Incidence of Parkinson’s disease and modifiable risk factors in Korean population: A longitudinal follow-up study of a nationwide cohort
Objective: We aimed to investigate the incidence of Parkinson’s disease (PD) by age and year for each sex as well as the modifiable risk factors…Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers
Objective: Implement depression screening using a validated instrument for people with Parkinson’s (PWP) as part of standard of care in the specialist movement disorders setting…Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population
Objective: We aim to evaluate the prevalence of depression in disorders including multiple sclerosis (MS), Parkinson's disease (PD), migraine, and stroke. Also, we detect risk…Risk factors of sleep disordered breathing in Veterans with Parkinson’s disease.
Objective: To investigate factors associated with the risk of sleep disordered breathing (SDB) in Veterans with Parkinson's disease (PD). Background: Sleep disordered breathing is common…Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease
Objective: The aim of this study was to explore the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 32
- Next Page »